Justice and drugmaker Mallinckrodt had flagged his concerns internally, but resigned after lacking "confidence" the company would pay back hundred of millions in Medicaid rebate underpayments, according to court documents and the tipster's attorneys. James Landolt, a former Mallinckrodt director, resigned in 2017 and filed a qui tam action in 2018 alleging Mallinckrodt ARD LLC knowingly failed to pay the correct rebates for its drug Acthar, an anticonvulsant for children. "It is easy to feel powerless in these types of situations. . . .
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Dr. Michael Harrington and his company, Genoverde Bioscience, Inc., have agreed to a $152,500 settlement to resolve allegations of making false and duplicative expense claims involving National Sci...